Indication

ZINPLAVA is a prescription medicine used to help decrease the risk of C. diff (Clostridium difficile infection) from coming back in people aged 18 years or older who are taking an antibiotic for C. diff and who have a high risk of C. diff coming back. ZINPLAVA is not an antibiotic and does not replace the antibiotic.


Indication

ZINPLAVA is a prescription medicine used to help decrease the risk of C. diff (Clostridium difficile infection) from coming back in people aged 18 years or older who are taking an antibiotic for C. diff and who have a high risk of C. diff coming back. ZINPLAVA is not an antibiotic and does not replace the antibiotic.

Important Safety Information About ZINPLAVA
 
  • Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.
  • The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.
  • Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.
  • The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.
  • The most common side effects that may happen up to four weeks after receiving ZINPLAVA are nausea, fever, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

Please read the accompanying Patient Information for ZINPLAVA and discuss it with your doctor.

The physician Prescribing Information also is available.


Important Safety Information About ZINPLAVA
  • Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.
  • The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.
  • The most common side effects that may happen up to four weeks after receiving ZINPLAVA are nausea, fever, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

Please read the accompanying Patient Information for ZINPLAVA and discuss it with your doctor. The physician Prescribing Information also is available.


 

BY CLICKING THIS LINK, YOU WILL BE LEAVING THE SITE

The link you have selected will take you to a site outside of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.

Merck does not review or control the content of any non-Merck site. Merck does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-Merck site.

Do you wish to continue?

 

E-MAIL THIS PAGE